(Q42542353)

English

Altropane, a SPECT or PET imaging probe for dopamine neurons: III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain

scientific article published on June 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 November 2017

Altropane, a SPECT or PET imaging probe for dopamine neurons: III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain (English)

1 reference

Europe PubMed Central

2 November 2017

0 references

author name string

Madras BK

1

1 reference

Europe PubMed Central

2 November 2017

Gracz LM

2

1 reference

Europe PubMed Central

2 November 2017

Fahey MA

3

1 reference

Europe PubMed Central

2 November 2017

Elmaleh D

4

1 reference

Europe PubMed Central

2 November 2017

Meltzer PC

5

1 reference

Europe PubMed Central

2 November 2017

Liang AY

6

1 reference

Europe PubMed Central

2 November 2017

Stopa EG

7

1 reference

Europe PubMed Central

2 November 2017

Babich J

8

1 reference

Europe PubMed Central

2 November 2017

Fischman AJ

9

1 reference

Europe PubMed Central

2 November 2017

publication date

1 June 1998

1 reference

Europe PubMed Central

2 November 2017

1 reference

Europe PubMed Central

2 November 2017

29

1 reference

Europe PubMed Central

2 November 2017

2

1 reference

Europe PubMed Central

2 November 2017

116-127

1 reference

Europe PubMed Central

2 November 2017

High-affinity binding of [125I]RTI-55 to dopamine and serotonin transporters in rat brain

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

Autoradiographic localization of cocaine binding sites by [3H]CFT ([3H]WIN 35,428) in the monkey brain.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

Compounds Affecting the Central Nervous System. 4. 3.beta.-Phenyltropane-2-carboxylic Esters and Analogs

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

Synthesis and ligand binding of nortropane derivatives: N-substituted 2beta-carbomethoxy-3beta-(4'-iodophenyl)nortropane and N-(3-iodoprop-(2E)-enyl)-2beta-carbomethoxy-3beta-(3',4'-disubstituted phenyl)nortropane. New high-affinity and selective co

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

PET study of [11C]beta-CIT binding to monoamine transporters in the monkey and human brain.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

Functional recovery in parkinsonian monkeys treated with GDNF

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

Synthesis and characterization of radioiodinated N-(3-iodopropen-1-yl)-2 beta-carbomethoxy-3 beta-(4-chlorophenyl)tropanes: potential dopamine reuptake site imaging agents.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

Single-photon emission tomography imaging of dopamine terminal innervation: a potential clinical tool in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

[3H]GBR-12935 binding to the dopamine transporter is decreased in the caudate nucleus in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's-diseased striatum

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

Distribution of cocaine recognition sites in monkey brain: II. Ex vivo autoradiography with [3H]CFT and [125I]RTI-55

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

[3H]CFT ([3H]WIN 35,428) accumulation in dopamine regions of monkey brain: comparison of a mature and an aged monkey.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

Distribution of cocaine recognition sites in monkey brain: I. In vitro autoradiography with [3H]CFT

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

Neurotrophic growth factors and neurodegenerative diseases: therapeutic potential of the neurotrophins and ciliary neurotrophic factor

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

Cocaine use increases [3H]WIN 35428 binding sites in human striatum.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

N-modified fluorophenyltropane analogs of cocaine with high affinity for cocaine receptors.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

Technepine: a high-affinity 99m-technetium probe to label the dopamine transporter in brain by SPECT imaging.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

Altropane, a SPECT or PET imaging probe for dopamine neurons: II. Distribution to dopamine-rich regions of primate brain

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

Substituted 3-phenyltropane analogs of cocaine: synthesis, inhibition of binding at cocaine recognition sites, and positron emission tomography imaging

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

A technetium-99m SPECT imaging agent which targets the dopamine transporter in primate brain.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

N-substituted analogs of 2 beta-carbomethoxy-3 beta- (4'-iodophenyl)tropane (beta-CIT) with selective affinity to dopamine or serotonin transporters in rat forebrain.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

Sodium dependent [3H]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in Parkinsons disease.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

Comparative evaluation of [3H]WIN 35428 and [3H]GBR 12935 as markers of dopamine innervation density in brain

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

Mapping dopamine transporters in the human brain with novel selective cocaine analog [125I]RTI-121.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

Altered striatal dopamine re-uptake site densities in habitually violent and non-violent alcoholics.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

Long-lasting inhibition of in vivo cocaine binding to dopamine transporters by 3 beta-(4-iodophenyl)tropane-2-carboxylic acid methyl ester: RTI-55 or beta CIT.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

Relationship between psychostimulant-induced "high" and dopamine transporter occupancy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

In vivo imaging of baboon and human dopamine transporters by positron emission tomography using [11C]WIN 35,428.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

Decreased density of human striatal dopamine uptake sites with age.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

Dopamine neuron agenesis in Nurr1-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

Dopamine transporter: biochemistry, pharmacology and imaging

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

[123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

Dopaminergic function in familial Parkinson's disease: A clinical and18F-dopa positron emission tomography study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

Synthesis and characterization of technetium-99m-labeled tropanes as dopamine transporter-imaging agents

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

The dopamine transporter is absent in parkinsonian putamen and reduced in the caudate nucleus

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

Species differences in dopamine transporters: postmortem changes and glycosylation differences.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

Species- and brain region-specific dopamine transporters: immunological and glycosylation characteristics

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C116%3A%3AAID-SYN3%3E3.0.CO%3B2-A

21 January 2018

Identifiers

10.1002/(SICI)1098-2396(199806)29:2<116::AID-SYN3>3.0.CO;2-A

1 reference

Europe PubMed Central

2 November 2017

1 reference

Europe PubMed Central

2 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42542353&oldid=1961264332"